Gilead Sciences Inc (GILD)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ
Market Cap: $207.86B
Last updated: Nov 17, 2026 at 4:44 PM ET
Gilead Sciences Inc (GILD) Stock Chart
Gilead Sciences (GILD) has a latest price of $170.26 on Nov 17, 2026, 3.6% below its 52-week high of $176.58. Its price rose 37.9% over the past 12 months. The month-end price rose 131.8% over the 10 years through Oct 2026, a compound annual rate of 8.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $170.68 in Oct 2026 and its lowest $58.15 in Oct 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GILD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GILD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 16.0%, and over 6 months it rose 32.1%. The month-end price rose 117.3% over the 3 years through Oct 2026, a compound annual rate of 29.5%.
| Period | Change |
|---|---|
| 1 month | +11.2% |
| 3 months | +16.0% |
| 6 months | +32.1% |
| 12 months | +37.9% |
| 12 months, with dividends | +40.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +117.3% | +29.5% |
| 5 years | +163.1% | +21.3% |
| 10 years | +131.8% | +8.8% |
Price by Year
Its best calendar year was 2025, when the price rose 32.9%, and its weakest was 2018, when it fell 12.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $170.68 | +39.1% |
| 2025 | $122.74 | +32.9% |
| 2024 | $92.37 | +14.0% |
| 2023 | $81.01 | -5.6% |
| 2022 | $85.85 | +18.2% |
| 2021 | $72.61 | +24.6% |
| 2020 | $58.26 | -10.3% |
| 2019 | $64.98 | +3.9% |
| 2018 | $62.55 | -12.7% |
| 2017 | $71.64 | 0.0% |
Trading Range
The price is 9.3% above its 50-day average of $155.84 and 20.7% above its 200-day average of $141.10.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $170.26 | |
| 52-week high | $176.58 | -3.6% |
| 52-week low | $114.81 | +48.3% |
| 50-day average | $155.84 | +9.3% |
| 200-day average | $141.10 | +20.7% |
Price Risk
Over 3 years, its largest fall from a peak was 26.6%.
| Measure | Value |
|---|---|
| 1-year beta | 0.38 |
| Largest fall, 1 year | -22.0% |
| Largest fall, 3 years | -26.6% |
Valuation
Gilead Sciences traded at 15.1x earnings at the end of 2025, against a 5-year median of 13.6x and a 10-year median of 10.0x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GILD
What is GILD's 1-year price change?
Gilead Sciences's price rose 37.9% over the past 12 months. With dividends included, the 12-month total return was 40.5%.
What is GILD's 5-year price change?
Gilead Sciences's month-end price rose 163.1% over the 5 years through Oct 2026, a compound annual rate of 21.3%. These figures leave out dividends.
What is GILD's 52-week high and low?
Gilead Sciences's 52-week high is $176.58 and its 52-week low is $114.81. Its latest price of $170.26 on Nov 17, 2026 is 3.6% below the high.
What is GILD's beta?
Gilead Sciences's 1-year beta against the S&P 500 is 0.38, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 22.0%.
Is the GILD chart free?
Yes. Advanced Charting for GILD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GILD pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts